In this video, Jeffrey R. Curtis, MD, MPH, discusses the importance of vaccinations among individuals with immune-mediated inflammatory diseases, the potential for poor outcomes if patients do not follow a vaccination schedule, and more.
In this video, Vibeke Strand, MD, discusses immunogenicity and its contributing factors among individuals with immune-mediated inflammatory diseases.
Lindsey Albenberg, DO, from Children's Hospital of Philadelphia, discusses the role of the microbiome, as well as its influence on immunity and the development of pediatric inflammatory bowel disease.
In this video, Diane Mould, PhD, from Projections Research, discusses the important role of monoclonal antibodies in the management of inflammatory diseases.
In this video, James T. Rosenbaum, MD, from Oregon Health and Science University, discusses the current management of ocular inflammatory diseases, the importance of collaboration between a rheumatologist and ophthalmologist, and more.
In this video, Gurjit S. Kaeley, MD, from the University of Florida, discusses the importance of imaging in psoriatic arthritis, how a rheumatologist can apply imaging to clinical practice, and more.
Jeffrey R. Curtis, MD, MPH, on Key Takeaways for Vaccinations in Immune-Mediated Inflammatory Diseases
In this video, Jeffrey R. Curtis, MD, MPH, highlights the key takeaways for specialists about vaccinations in immune-mediated inflammatory diseases.
In this video, Gurjit S. Kaeley, MD, from the University of Florida, discusses the importance of evaluating enthesitis in individuals with psoriatic arthritis, and more.
In this video, Vibeke Strand, MD, highlights current JAK inhibitors for the treatment of immune-mediated inflammatory diseases, how they may be used in the future, and more.
Emergency department use and hospitalizations are a common cost among patients with severe autoimmune diseases and drive high healthcare spending. Miguel Reguerio, MD, discusses the role of medical homes and how they could potentially address patients’ needs. Among patients with inflammatory bowel diseases (IBD), the top 25%